Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

2008

  1. High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: Results from the TOLERANCE study

    International Journal of Clinical Practice, Vol. 62, Núm. 5, pp. 723-728

  2. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: The TOLERANCE study

    Cardiovascular Therapeutics, Vol. 26, Núm. 1, pp. 2-9

2007

  1. Adecuación del tratamiento de los pacientes hipertensos con síndrome metabólico

    Medicina Clinica, Vol. 128, Núm. 17, pp. 647-651